A Canadian company is interested in establishing a vaccine manufacturing facility in the Philippines
Negotiations are already underway between the Philippine government and a Canadian biotech firm to establish a vaccine production facility in the nation, according to Rodolfo Robles, the Philippine Ambassador to Canada.
When asked about the talks with Medicago in an online Palace briefing, Robles said they would continue “more quickly” and officially once the non-disclosure agreement was authorized by the Philippine government via the Department of Science and Technology (DOST).
It was our pharmaceutical ecozone in Bulacan, I believe, that he mentioned, and he offered them all the benefits of setting up a manufacturing (unit) in the Philippines, including trade-free taxes, free capital imports, and other incentives, he added.
Robles said that the Philippines has also indicated an interest in receiving part of the surplus coronavirus disease 2019 (Covid-19) vaccinations from Canada, which amount to about 100 million doses.
He claims that Canada has 180 million doses of the Covid-19 vaccine despite having a population of only about 40 million people.
In addition, he said, “I had the Philippines listed as one of the countries interested in receiving Canada’s surplus.”
Robles stated that Canada’s population is expected to be fully immunized by the middle of the fourth quarter of this year.
“Consequently, we will already know how many surpluses Canada will have before the end of the year. And I’m keeping a close eye on the possibility of obtaining some surplus directly from Canada, which would be fantastic “he explained.